CD4 and AIDS: The study population consisted of clients diagnosed with AHD, defined by CD4 counts below 200 cells/mm3 or presenting with an AIDS‐defining condition based on World Health Organization guideline and tested for TB using the lipoarabinomannan assay (TB‐LAM), data was extracted from electronic medical records (EMR) of 19 One Stop Shops (OSS) under the United States Agency for International Development (USAID)‐funded KP CARE 1 project between 2022 to March 2024.